1. Home
  2. BEEM vs ATNM Comparison

BEEM vs ATNM Comparison

Compare BEEM & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

HOLD

Current Price

$1.15

Market Cap

28.6M

Sector

Technology

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$0.78

Market Cap

31.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEM
ATNM
Founded
2006
2000
Country
United States
United States
Employees
220
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
31.7M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
BEEM
ATNM
Price
$1.15
$0.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$3.50
$4.50
AVG Volume (30 Days)
395.2K
99.6K
Earning Date
04-09-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.17
EPS
N/A
0.71
Revenue
N/A
$90,000.00
Revenue This Year
$40.48
N/A
Revenue Next Year
$32.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.11
52 Week Low
$0.97
$0.74
52 Week High
$4.04
$1.81

Technical Indicators

Market Signals
Indicator
BEEM
ATNM
Relative Strength Index (RSI) 52.04 33.74
Support Level $1.13 N/A
Resistance Level $1.66 $1.38
Average True Range (ATR) 0.06 0.04
MACD 0.02 -0.00
Stochastic Oscillator 88.08 24.44

Price Performance

Historical Comparison
BEEM
ATNM

About BEEM Beam Global

Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: